The Full Wiki

More info on L-733,060

L-733,060: Wikis

Note: Many of our articles have direct quotes from sources you can cite, within the Wikipedia article! This article doesn't yet, but we're working on it! See more info or our list of citable articles.


From Wikipedia, the free encyclopedia

Systematic (IUPAC) name
CAS number 148700-85-0
ATC code  ?
PubChem 132846
Chemical data
Formula C 20H19F6NO 
Mol. mass 403.361 g/mol
SMILES eMolecules & PubChem
Pharmacokinetic data
Bioavailability  ?
Metabolism  ?
Half life  ?
Excretion  ?
Therapeutic considerations
Pregnancy cat.  ?
Legal status
Routes  ?

L-733,060 is a drug developed by Merck, Sharpe & Dohme which acts as an orally active, non-peptide, selective antagonist for the NK1 receptor, binding with a Ki of 0.08nM.[1] Only one enantiomer is active which has made it the subject of several asymmetric synthesis efforts.[2][3][4]

L-733,060 has antidepressant[5][6] and anxiolytic effects in animal studies,[7] and reduces both the dopamine release and neurotoxicity produced by methamphetamine and cocaine.[8][9][10][11][12] It shows antiinflammatory and anti-hepatotoxic effects in animals,[13][14] and counteracts the development of hyperalgesia following nerve injury.[15][16] It also has anticancer effects in a variety of in vitro models.[17][18][19]

See also


  1. ^ Seabrook GR, Shepheard SL, Williamson DJ, Tyrer P, Rigby M, Cascieri MA, Harrison T, Hargreaves RJ, Hill RG. L-733,060, a novel tachykinin NK1 receptor antagonist; effects in [Ca2+]i mobilisation, cardiovascular and dural extravasation assays. European Journal of Pharmacology. 1996 Dec 12;317(1):129-35. PMID 8982729
  2. ^ Liu LX, Ruan YP, Guo ZQ, Huang PQ. A general approach to (5S,6R)-6-alkyl-5-benzyloxy-2-piperidinones: application to the asymmetric syntheses of neurokinin substance P receptor antagonist (-)-L-733,061 and (-)-deoxocassine. Journal of Organic Chemistry. 2004 Sep 3;69(18):6001-9. PMID: 15373484
  3. ^ Tsai MR, Chen BF, Cheng CC, Chang NC. A novel and highly regioselective approach to 5-methoxy-6-substituted-3-sulfonyl-delta-enlactams from 5-methoxy-3-sulfonyl glutarimide: synthesis of cis-2-substituted-3-piperidinols. Journal of Organic Chemistry. 2005 Mar 4;70(5):1780-5. PMID 15730301
  4. ^ Liu RH, Fang K, Wang B, Xu MH, Lin GQ. Concise asymmetric synthesis of (+)-CP-99,994 and (+)-L-733,060 via efficient construction of homochiral syn-1,2-diamines and syn-1,2-amino alcohols. Journal of Organic Chemistry. 2008 Apr 18;73(8):3307-10. PMID 18331063
  5. ^ Varty GB, Cohen-Williams ME, Hunter JC. The antidepressant-like effects of neurokinin NK1 receptor antagonists in a gerbil tail suspension test. Behavioural Pharmacology. 2003 Feb;14(1):87-95. PMID 12576885
  6. ^ Wallace-Boone TL, Newton AE, Wright RN, Lodge NJ, McElroy JF. Behavioral and pharmacological validation of the gerbil forced-swim test: effects of neurokinin-1 receptor antagonists. Neuropsychopharmacology. 2008 Jul;33(8):1919-28. PMID 17912250
  7. ^ Varty GB, Cohen-Williams ME, Morgan CA, Pylak U, Duffy RA, Lachowicz JE, Carey GJ, Coffin VL. The gerbil elevated plus-maze II: anxiolytic-like effects of selective neurokinin NK1 receptor antagonists. Neuropsychopharmacology. 2002 Sep;27(3):371-9. PMID 12225694
  8. ^ Kraft M, Noailles P, Angulo JA. Substance P modulates cocaine-evoked dopamine overflow in the striatum of the rat brain. Annals of the New York Academy of Sciences. 2001 Jun;937:121-31. PMID 11458533
  9. ^ Yu J, Allison S, Ibrahim D, Cadet JL, Angulo JA. Ontogeny of neurokinin-1 receptor mediation of methamphetamine neurotoxicity in the striatum of the mouse brain. Annals of the New York Academy of Sciences. 2002 Jun;965:247-53. PMID 12105100
  10. ^ Noailles PA, Angulo JA. Neurokinin receptors modulate the neurochemical actions of cocaine. Annals of the New York Academy of Sciences. 2002 Jun;965:267-73. PMID 12105102
  11. ^ Yu J, Cadet JL, Angulo JA. Neurokinin-1 (NK-1) receptor antagonists abrogate methamphetamine-induced striatal dopaminergic neurotoxicity in the murine brain. Journal of Neurochemistry. 2002 Nov;83(3):613-22. PMID 12390523
  12. ^ Loonam TM, Noailles PA, Yu J, Zhu JP, Angulo JA. Substance P and cholecystokinin regulate neurochemical responses to cocaine and methamphetamine in the striatum. Life Sciences. 2003 Jun 27;73(6):727-39. PMID 12801594
  13. ^ Bang R, Sass G, Kiemer AK, Vollmar AM, Neuhuber WL, Tiegs G. Neurokinin-1 receptor antagonists CP-96,345 and L-733,060 protect mice from cytokine-mediated liver injury. Journal of Pharmacology and Experimental Therapeutics. 2003 Apr;305(1):31-9. PMID 12649350
  14. ^ Bang R, Biburger M, Neuhuber WL, Tiegs G. Neurokinin-1 receptor antagonists protect mice from CD95- and tumor necrosis factor-alpha-mediated apoptotic liver damage. Journal of Pharmacology and Experimental Therapeutics. 2004 Mar;308(3):1174-80. PMID 14617692
  15. ^ Jang JH, Nam TS, Paik KS, Leem JW. Involvement of peripherally released substance P and calcitonin gene-related peptide in mediating mechanical hyperalgesia in a traumatic neuropathy model of the rat. Neuroscience Letters. 2004 Apr 29;360(3):129-32. PMID 15082150
  16. ^ Rittner HL, Lux C, Labuz D, Mousa SA, Schäfer M, Stein C, Brack A. Neurokinin-1 receptor antagonists inhibit the recruitment of opioid-containing leukocytes and impair peripheral antinociception. Anesthesiology. 2007 Dec;107(6):1009-17. PMID 18043070
  17. ^ Muñoz M, Rosso M, Coveñas R, Montero I, González-Moles MA, Robles MJ. Neurokinin-1 receptors located in human retinoblastoma cell lines: antitumor action of its antagonist, L-732,138. Investigative Ophthalmology and Visual Science. 2007 Jun;48(6):2775-81. PMID 17525212
  18. ^ Muñoz M, Rosso M, Aguilar FJ, González-Moles MA, Redondo M, Esteban F. NK-1 receptor antagonists induce apoptosis and counteract substance P-related mitogenesis in human laryngeal cancer cell line HEp-2. Investigational New Drugs. 2008 Apr;26(2):111-8. PMID 17906845
  19. ^ Rosso M, Robles-Frías MJ, Coveñas R, Salinas-Martín MV, Muñoz M. The NK-1 receptor is expressed in human primary gastric and colon adenocarcinomas and is involved in the antitumor action of L-733,060 and the mitogenic action of substance P on human gastrointestinal cancer cell lines. Tumour Biology. 2008;29(4):245-54. PMID 18781096

Got something to say? Make a comment.
Your name
Your email address